As Covid-19 spread across the country, cancer programs quickly reacted with operational and clinical changes to ensure they could continue treating immunocompromised patients as safely as possible. And while patients are generally more concerned about their cancer than they are of Covid-19, they are still often confused, scared, and anxious about entering medical facilities for screening and treatment.